Concepedia

Neal Azrolan

NA

Statistics

Publications

24

Citations

2.3K

H-Index

22

Active since

1989

Affiliations

Rockefeller University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

New York University

United States Military Academy

Covance (United States)

Neal Azrolan is an author at Rockefeller University specializing in life sciences, biochemistry, and lipoprotein metabolism.

Publications per year

1989–2009

24

Publications

24

Hypertriglyceridemia as a Result of Human apo <i>CII</i> Gene Expression in Transgenic Mice

Yasushi Ito, Neal Azrolan, Anita M. O'Connell et al. · Science · 1990 · 543 citations

, , +14

Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme

Kelem Kassahun, Ian McIntosh, Donghui Cui et al. · Drug Metabolism and Disposition · 2007 · 275 citations

, , +16

Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.

Dov Gavish, Neal Azrolan, J L Breslow · Journal of Clinical Investigation · 1989 · 156 citations · Full text

, , +12

Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice.

Tony Hayek, Yasushi Ito, Neal Azrolan et al. · Journal of Clinical Investigation · 1993 · 147 citations · Full text

, , +16

Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.

Tony Hayek, Neal Azrolan, Roy B. Verdery et al. · Journal of Clinical Investigation · 1993 · 132 citations · Full text

, , +17

1–5 of 24